Cummins, N. W., Baker, J., Chakraborty, R., Dean, P. G., Garcia-Rivera, E., Krogman, A., Kumar, S., Kuzmichev, Y. V., Laird, G. M., Landay, A., Lichterfeld, M., Mahmood, M., Martinson, J., Maynes, M., Natesampillai, S., Rajkumar, V., Rassadkina, Y., Ritter, K. D., Rivera, C. G., Rizza, S. A., Subramanian, K., Tande, A. J., Wonderlich, E. R., Whitaker, J. A., Zeuli, J., & Badley, A. D. (2021). single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo.. EClinicalMedicine, 42, . http://access.bl.uk/ark:/81055/vdc_100148066952.0x000006